153 related articles for article (PubMed ID: 18055065)
1. Financial consequences of hospital-acquired bacteraemia in three Belgian hospitals in 2003 and 2004.
Pirson M; Leclercq P; Jackson T; Leclercq M; Garrino M; Sion C
J Hosp Infect; 2008 Jan; 68(1):9-16. PubMed ID: 18055065
[TBL] [Abstract][Full Text] [Related]
2. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
[TBL] [Abstract][Full Text] [Related]
3. Costs associated with hospital-acquired bacteraemia in an Indian hospital: a case-control study.
Kothari A; Sagar V; Ahluwalia V; Pillai BS; Madan M
J Hosp Infect; 2009 Feb; 71(2):143-8. PubMed ID: 19058876
[TBL] [Abstract][Full Text] [Related]
4. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
[TBL] [Abstract][Full Text] [Related]
5. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs.
Vrijens F; Hulstaert F; Devriese S; van de Sande S
Epidemiol Infect; 2012 Jan; 140(1):126-36. PubMed ID: 21320376
[TBL] [Abstract][Full Text] [Related]
6. Prospective casemix-based funding, analysis and financial impact of cost outliers in all-patient refined diagnosis related groups in three Belgian general hospitals.
Pirson M; Martins D; Jackson T; Dramaix M; Leclercq P
Eur J Health Econ; 2006 Mar; 7(1):55-65. PubMed ID: 16416135
[TBL] [Abstract][Full Text] [Related]
7. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
Rosenthal VD; Guzman S; Migone O; Safdar N
Am J Infect Control; 2005 Apr; 33(3):157-61. PubMed ID: 15798670
[TBL] [Abstract][Full Text] [Related]
8. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
[TBL] [Abstract][Full Text] [Related]
9. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
[TBL] [Abstract][Full Text] [Related]
10. Economics of central line--associated bloodstream infections.
Shannon RP; Patel B; Cummins D; Shannon AH; Ganguli G; Lu Y
Am J Med Qual; 2006; 21(6 Suppl):7S-16S. PubMed ID: 17077414
[TBL] [Abstract][Full Text] [Related]
11. [Bacteraemia at a second level hospital: epidemiological study, analysis of pronostic factors associated to mortality and economic cost estimation].
Hernández-Roca JJ; García-Vázquez E; Hernández A; Canteras M; Herrero JA; Cascales E; Mené-Fenor E; Gómez-Gómez J
Rev Esp Quimioter; 2013 Jun; 26(2):119-27. PubMed ID: 23817650
[TBL] [Abstract][Full Text] [Related]
12. [A method to determine hospital costs associated with nosocomial infections].
Gianino MM; Vallino A; Anselmo E; Minniti D; Abbona F; Mineccia C; Silvaplana P; Zotti CM
Ann Ig; 2007; 19(4):381-92. PubMed ID: 17937330
[TBL] [Abstract][Full Text] [Related]
13. Costs of nosocomial Clostridium difficile-associated diarrhoea.
Vonberg RP; Reichardt C; Behnke M; Schwab F; Zindler S; Gastmeier P
J Hosp Infect; 2008 Sep; 70(1):15-20. PubMed ID: 18602185
[TBL] [Abstract][Full Text] [Related]
14. Costs associated with readmissions in Belgian acute-care hospitals.
Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
Acta Clin Belg; 2013; 68(4):263-7. PubMed ID: 24455795
[TBL] [Abstract][Full Text] [Related]
15. [Costs for acute, stationary treatment of polytrauma patients].
Schmelz A; Ziegler D; Beck A; Kinzl L; Gebhard F
Unfallchirurg; 2002 Nov; 105(11):1043-8. PubMed ID: 12402131
[TBL] [Abstract][Full Text] [Related]
16. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs.
Song X; Srinivasan A; Plaut D; Perl TM
Infect Control Hosp Epidemiol; 2003 Apr; 24(4):251-6. PubMed ID: 12725353
[TBL] [Abstract][Full Text] [Related]
17. Applying the 3M All Patient Refined Diagnosis Related Groups Grouper to measure inpatient severity in the VA.
Shen Y
Med Care; 2003 Jun; 41(6 Suppl):II103-10. PubMed ID: 12773832
[TBL] [Abstract][Full Text] [Related]
18. [Study of costs associated with catheter-related bacteremia].
Morís de la Tassa J; Fernández Muñoz P; Antuña Egocheaga A; Gutiérrez del Río MC; de la Fuente García B; Cartón Sánchez JA
Rev Clin Esp; 1998 Oct; 198(10):641-6. PubMed ID: 9844450
[TBL] [Abstract][Full Text] [Related]
19. Additional direct medical costs of nosocomial infections: an estimation from a cohort of patients in a French university hospital.
Defez C; Fabbro-Peray P; Cazaban M; Boudemaghe T; Sotto A; Daurès JP
J Hosp Infect; 2008 Feb; 68(2):130-6. PubMed ID: 18201796
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic consequences of ventilator-associated pneumonia.
Amin A
Clin Infect Dis; 2009 Aug; 49 Suppl 1():S36-43. PubMed ID: 19619020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
